Holen Sie sich die Stockscreener-App
93.34
1.09%
-1.2811
Schlusskurs vom Vortag:
$94.62
Offen:
$95.77
24-Stunden-Volumen:
403.70K
Relative Volume:
0.24
Marktkapitalisierung:
$12.48B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
69.66
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+7.21%
1M Leistung:
+5.85%
6M Leistung:
+63.31%
1J Leistung:
+8.14%
1-Tages-Spanne:
$93.20
$96.06
1-Wochen-Bereich:
$87.00
$101.40
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
93.21 | 12.66B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
125.48 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.78 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.17 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.59 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.14 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Globus Medical stock price target raised to $112 by Canaccord on strong results - Investing.com UK
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price - Chartmill
Is Globus Medical Inc. stock dividend yield sustainable2025 Trade Ideas & Long-Term Growth Stock Strategies - ulpravda.ru
Can Globus Medical Inc. stock maintain growth trajectoryTrade Exit Summary & Entry Point Confirmation Signals - ulpravda.ru
Why Globus Medical Inc. stock could benefit from AI revolution2025 Top Gainers & Community Shared Stock Ideas - ulpravda.ru
Will Globus Medical Inc. stock benefit from automationNew Guidance & Stock Portfolio Risk Control - ulpravda.ru
Insider plans sale of 3,594 common shares under Rule 144 | GMED SEC FilingForm 144 - Stock Titan
GMED (GMED) holder files to sell 2,000 shares after RSU vesting - Stock Titan
Globus Medical jumps 9% after upbeat revenue and earnings outlook - Yahoo Finance
Globus Medical (GMED) Price Target Raised to $115.00 by Piper Sa - GuruFocus
Globus Medical stock hits all-time high at 99.5 USD By Investing.com - Investing.com Canada
Globus Medical climbs on better-than-expected Q4, FY outlook - TradingView — Track All Markets
US-based Globus Medical anticipates 25.2% sales increase in Q4 2025 - Medical Buyer
Citizens reiterates Market Perform rating on Globus Medical stock By Investing.com - Investing.com Canada
Globus Medical (GMED) Surges on Strong Sales Projections - GuruFocus
Jon Najarian: Globus Medical shares surge 9 percent on strong Q4 sales projection - Traders Union
Jefferies raises Globus Medical stock price target to $115 on strong Q4 - Investing.com Canada
Why Globus Medical Stock Is Flying Higher in After-Hours Trading - The Globe and Mail
Globus Medical Surges On Preliminary Q4 And FY25 Sales Results; Issues FY26 Guidance - Nasdaq
Globus Medical Stock Pre-Market (+9.3%): Strong Prelim Q4 Sales & Upbeat 2026 Guidance - Trefis
Globus Medical reports 25.2% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Globus Medical (GMED) Projects Strong Revenue Growth for 2025 - GuruFocus
GMED Sees Strong Q4 Results, Eyes Growth in 2026 - GuruFocus
Globus Medical Q4 Preliminary Sales Rise 25% From Year Earlier; Shares Jump After Hours - MarketScreener
GMED Stock Sees Significant Annual Growth - GuruFocus
GMED Raises Revenue Forecast for FY26 - GuruFocus
Globus Medical reports 25.2% revenue growth in Q4 2025 - Investing.com India
Globus Medical's preliminary Q4 sales beat estimates - TradingView — Track All Markets
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results - The Manila Times
Globus Medical (GMED) shares preliminary 2025 sales results and 2026 guidance - Stock Titan
Globus posts record 2025 sales, sets 2026 revenue guidance up to $3.22B - Stock Titan
Stifel raises Globus Medical stock price target to $90 on strong outlook - Investing.com Canada
Will Globus Medical Inc. stock attract ESG investors2026 world cup usa national team qualification top scorers counter attacking winner prediction tactical review - ulpravda.ru
Globus Medical (GMED) director gifts 6,100 Class A shares, updates holdings - Stock Titan
Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A - TradingView — Track All Markets
Does Globus Medical (NYSE:GMED) Deserve A Spot On Your Watchlist? - Yahoo Finance
Allspring Global Investments Holdings LLC Acquires 312,149 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Globus Medical Inc: The Spine Stock Wall Street Slept On (Until Now) - AD HOC NEWS
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates - sharewise.com
The Truth About Globus Medical Inc: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
Fort Washington Investment Advisors Inc. OH Raises Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Listed in NYSE Composite Healthcare Group - Kalkine Media
Should I hold or sell Globus Medical Inc. stock in 2025Debt-to-Equity Ratio Analysis & Free High Yield Investment Strategies - bollywoodhelpline.com
Globus Medical, Inc. $GMED is Paradice Investment Management LLC's Largest Position - MarketBeat
BTIG reiterates Neutral rating on Globus Medical stock after strong Q3 - Investing.com Canada
Audubon’s Globus Medical Makes Game-Changing Acquisition - MSN
Boston Trust Walden Corp Takes $67.89 Million Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Globus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - FinancialContent
Swedbank AB Increases Position in Globus Medical, Inc. $GMED - MarketBeat
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):